Search Results - "Hant, Faye N"

Predictive Significance of Serum Interferon‐Inducible Protein Score for Response to Treatment in Systemic Sclerosis–Related Interstitial Lung Disease by Assassi, Shervin, Li, Ning, Volkmann, Elizabeth R., Mayes, Maureen D., Rünger, Dennis, Ying, Jun, Roth, Michael D., Hinchcliff, Monique, Khanna, Dinesh, Frech, Tracy, Clements, Philip J., Furst, Daniel E., Goldin, Jonathan, Bernstein, Elana J., Castelino, Flavia V., Domsic, Robyn T., Gordon, Jessica K., Hant, Faye N., Shah, Ami A., Shanmugam, Victoria K., Steen, Virginia D., Elashoff, Robert M., Tashkin, Donald P.

“…Objective Response to immunosuppression is highly variable in systemic sclerosis (SSc)–related interstitial lung disease (ILD). This study was undertaken to…”
Get full text

Surfactant Protein D and KL-6 as Serum Biomarkers of Interstitial Lung Disease in Patients with Scleroderma by HANT, Faye N, LUDWICKA-BRADLEY, Anna, WANG, He-Jing, NING LI, ELASHOFF, Robert, TASHKIN, Donald P, SILVER, Richard M

“…Objective. To assess whether serum concentrations of surfactant protein D (SP-D) and Krebs von den Lungen-6 (KL-6), glycoproteins expressed by type II…”
Get full text

Imaging of Scleroderma by Chapin, Russell, MD, Hant, Faye N., DO, MSCR

“…Systemic sclerosis is a rare autoimmune condition that affects a variety of organ systems. Knowledge of the imaging features in this patient population is…”
Get full text

Review of Current Immunologic Therapies for Hidradenitis Suppurativa by Hant, Faye N., McNish, Sean, Zaman, Nadia Meher, Shanmugam, Victoria K.

“…Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory disease of apocrine gland-bearing skin which affects approximately 1–4% of the population…”
Get full text

Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States by Bernstein, Elana J., Assassi, Shervin, Castelino, Flavia V., Chung, Lorinda, Correia, Chase, Evnin, Luke B., Frech, Tracy M., Gordon, Jessica K., Skaug, Brian A., Hant, Faye N., Hummers, Laura K., Sandorfi, Nora, Shah, Ami A., Shanmugam, Victoria K., Steen, Virginia D., Khanna, Dinesh

“…Objective Although a high‐resolution computed tomography (HRCT) scan of the chest is the gold standard test for the detection of interstitial lung disease…”
Get full text

Systemic Sclerosis and Perceptions of Quality in Primary Care by Toci, Ashley L., MD, Hyer, J. Madison, MS, Silver, Richard M., MD, Nietert, Paul J., PhD, Hant, Faye N., DO, MSCR

“…Abstract Background Among patients with systemic sclerosis (SSc), early recognition of potentially life-threatening organ involvement is critical. Because…”
Get full text

Elevated expression of cav‐1 in a subset of SSc fibroblasts contributes to constitutive Alk1/Smad1 activation by Haines, Paul, Hant, Faye N., Lafyatis, Robert, Trojanowska, Maria, Bujor, Andreea M.

“…Previous studies have shown that the transforming growth factor (TGF)β/Alk1/Smad1 signaling pathway is constitutively activated in a subset of systemic…”
Get full text

Pulmonary Manifestations of Scleroderma and Mixed Connective Tissue Disease by Hant, Faye N., DO, MSCR, Herpel, Laura B., MD, Silver, Richard M., MD

“…Pulmonary manifestations are common in connective tissue diseases, and are associated with significant morbidity and mortality in this patient population…”
Get full text

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial by Khanna, Dinesh, Spino, Cathie, Johnson, Sindhu, Chung, Lorinda, Whitfield, Michael L., Denton, Christopher P., Berrocal, Veronica, Franks, Jennifer, Mehta, Bhavan, Molitor, Jerry, Steen, Virginia D., Lafyatis, Robert, Simms, Robert W., Gill, Anna, Kafaja, Suzanne, Frech, Tracy M., Hsu, Vivien, Domsic, Robyn T., Pope, Janet E., Gordon, Jessica K., Mayes, Maureen D., Schiopu, Elena, Young, Amber, Sandorfi, Nora, Park, Jane, Hant, Faye N., Bernstein, Elana J., Chatterjee, Soumya, Castelino, Flavia V., Ajam, Ali, Wang, Yue, Wood, Tammara, Allanore, Yannick, Matucci‐Cerinic, Marco, Distler, Oliver, Singer, Ora, Bush, Erica, Fox, David A., Furst, Daniel E.

“…Objective T cells play a key role in the pathogenesis of early systemic sclerosis. This study was undertaken to assess the safety and efficacy of abatacept in…”
Get full text

Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults With Early Diffuse Cutaneous Systemic Sclerosis by Bernstein, Elana J., Jaafar, Sara, Assassi, Shervin, Domsic, Robyn T., Frech, Tracy M., Gordon, Jessica K., Broderick, Rachel J., Hant, Faye N., Hinchcliff, Monique E., Shah, Ami A., Shanmugam, Victoria K., Steen, Virginia D., Khanna, Dinesh

“…Objective Interstitial lung disease (ILD) is the leading cause of death in patients with systemic sclerosis (SSc). Although pulmonary function tests (PFTs) are…”
Get full text

Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts by Bujor, Andreea M., Nakerakanti, Sashidar, Morris, Erin, Hant, Faye N., Trojanowska, Maria

“…Please cite this article as: Akt inhibition up‐regulates MMP1 through a CCN2‐dependent pathway in human dermal fibroblasts. Experimental Dermatology 2010. : …”
Get full text

Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile by Skaug, Brian, Khanna, Dinesh, Swindell, William R, Hinchcliff, Monique E, Frech, Tracy M, Steen, Virginia D, Hant, Faye N, Gordon, Jessica K, Shah, Ami A, Zhu, Lisha, Zheng, W Jim, Browning, Jeffrey L, Barron, Alexander M S, Wu, Minghua, Visvanathan, Sudha, Baum, Patrick, Franks, Jennifer M, Whitfield, Michael L, Shanmugam, Victoria K, Domsic, Robyn T, Castelino, Flavia V, Bernstein, Elana J, Wareing, Nancy, Lyons, Marka A, Ying, Jun, Charles, Julio, Mayes, Maureen D, Assassi, Shervin

“…Determine global skin transcriptome patterns of early diffuse systemic sclerosis (SSc) and how they differ from later disease. Skin biopsy RNA from 48 patients…”
Get more information

Training the Next Generation of Rheumatologists: What Is the Best Way to Teach Fellows About Scleroderma? by Rodríguez-Reyna, Tatiana S, Hant, Faye N, Cutolo, Maurizio, Smith, Vanessa

“…Rheumatology is rich in educational opportunities, learning about a variety of diseases. Rheumatology subspecialty training is a time of unparalleled learning,…”
Get full text

Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18 by Volkmann, Elizabeth R., Tashkin, Donald P., Kuwana, Masataka, Li, Ning, Roth, Michael D., Charles, Julio, Hant, Faye N., Bogatkevich, Galina S., Akter, Tanjina, Kim, Grace, Goldin, Jonathan, Khanna, Dinesh, Clements, Philip J., Furst, Daniel E., Elashoff, Robert M., Silver, Richard M., Assassi, Shervin, Theodore, A. C., Simms, R. W., Kissin, E., Cheong, F. Y., Steen, V. D., Read, C. A., Fridley, C., Zulmatashvili, M., Wise, R. A., Wigley, F. M., Hummers, L., Leatherman, G., Silver, R. M., Strange, C., Hant, F. N., Ham, J., Gibson, K., Rosson, D., Tashkin, D. P., Elashoff, R. M., Roth, M. D., Clements, P. J., Furst, D., Volkmann, E. R., Kafaja, S., Kleerup, E., Elashoff, D., Goldin, J., Ariola, E., Marlis, G., Mason‐Berry, J., Saffold, P., Rodriguez, M., Guzman, L., Brook, J., Golden, J., Connolly, M. K., Eller, A., Leong, D., Lalosh, M., Obata, J., Volkov, S., Schraufnagel, D., Arami, S., Franklin, D., Varga, J., Dematte, J., Hinchcliff, M., DeLuca, C., Donnelly, H., Marlin, C., Riley, D. J., Hsu, V. M., McCloskey, D. A., Phillips, K., Khanna, D., Martinez, F. J., Schiopu, E., Konkle, J., Mayes, M., Patel, B., Assassi, S., Tan, F., Fischer, A., Swigris, J., Meehan, R., Brown, K., Warren, T., Morrison, M., Scholand, M. B., Frecht, T., Carey, P., Villegas, M., Molitor, J., Carlson, P.

“…Objective To investigate the relationship between Krebs von den Lungen 6 (KL‐6) and CCL18 levels and the severity and progression of systemic sclerosis…”
Get full text

Virtual Learning and Assessment in Rheumatology Fellowship Training: Objective Structured Clinical Examination Revisited by Wolfe, Rachel M., Hant, Faye N., Ishizawar, Rumey C., Criscione‐Schreiber, Lisa G., Jonas, Beth L., O'Rourke, Kenneth S., Bolster, Marcy B.

“…Objective With the onset of the COVID‐19 pandemic, an annual multi‐institutional face‐to‐face rheumatology objective structured clinical examination (ROSCE)…”
Get full text

CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization by Luebker, Sarah, Frech, Tracy M, Assassi, Shervin, Skaug, Brian, Gordon, Jessica K, Lakin, Kimberly, Bernstein, Elana J, Luo, Yiming, Steen, Virginia D, Shah, Ami A, Hummers, Laura K, Richardson, Carrie, Moore, Duncan F, Khanna, Dinesh, Castelino, Flavia V, Chung, Lorinda, Kapoor, Puneet, Hant, Faye N, Shanmugam, Victoria K, VanBuren, John M, Alvey, Jessica, Harding, Monica, Shah, Ankoor, Makol, Ashima, Lebiedz-Odrobina, Dorota, Thomas, Julie K, Volkmann, Elizabeth R, Molitor, Jerry A, Sandorfi, Nora

“…Abstract Objectives SSc is associated with increased health-care resource utilization and economic burden. The Collaborative National Quality and Efficacy…”
Get full text

Drugs that may harm bone: Mitigating the risk by Hant, Faye N, Bolster, Marcy B

“…Glucocorticoids, proton pump inhibitors, selective serotonin reuptake inhibitors (SSRIs), certain antiepileptic drugs, and aromatase inhibitors have…”
Get full text

Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry by Hsu, Vivien M, Chung, Lorinda, Hummers, Laura K, Shah, Ami, Simms, Robert, Bolster, Marcy, Hant, Faye N, Silver, Richard M, Fischer, Aryeh, Hinchcliff, Monique E, Varga, John, Goldberg, Avram Z, Derk, Chris T, Schiopu, Elena, Khanna, Dinesh, Shapiro, Lee S, Domsic, Robyn T, Medsger, Thomas, Mayes, Maureen D, Furst, Daniel, Csuka, Mary Ellen, Molitor, Jerry A, Saketkoo, Lesley Ann, Salazar, Christian R, Steen, Virginia D

“…We sought to identify predictors of mortality and cardiopulmonary hospitalizations in patients at risk for pulmonary hypertension (PH) and enrolled in PHAROS,…”
Get full text

Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures? by Frech, Tracy M., VanBuren, John M., Startup, Emily, Assassi, Shervin, Bernstein, Elana J., Castelino, Flavia V., Chung, Lorinda, Correia, Chase, Gordon, Jessica K., Hant, Faye N., Hummers, Laura, Khanna, Dinesh, Sandorfi, Nora, Shah, Ami A., Shanmugam, Victoria K., Steen, Virginia, Evnin, Luke

“…The objective of this analysis is to examine whether the severity of systemic sclerosis (SSc)-hand involvement influences patient-reported outcome measure…”
Get full text

The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation by Luebker, Sarah, Frech, Tracy M, Assassi, Shervin, Gordon, Jessica K, Bernstein, Elana J, Steen, Virginia D, Shah, Ami A, Hummers, Laura K, Richardson, Carrie, Khanna, Dinesh, Castelino, Flavia V, Chung, Lorinda, Hant, Faye N, Shanmugam, Victoria K, VanBuren, John M, Alvey, Jessica, Harding, Monica, Sandorfi, Nora

“…Systemic Sclerosis (SSc) is frequently associated with gastrointestinal tract (GIT) involvement. The Collaborative National Quality and Efficacy Registry…”
Get more information